Maze Therapeutics, Inc.
MAZEBiotechnology
$31.93+0.63%As of Oct 29vs prior close
- Market cap
- $1.8B
- P/E (TTM)
- –
- From 52W high
- −38.40%
- EPS (LTM)
- -$2.34
- Revenue (YE24)
- $167.5M
- Dividend yield
- 0.00%
Nomior Score
34
Emerging BreakoutSpeculativeBottom 20% of the scored universe
Growth42
Quality52
Value44
Momentum29
Resilience40
Connections
Revenue to profitQ1 YE26
The operating loss was 133% of revenue.
Who owns it
2funds, 1 tracked portfolio